Literature DB >> 10785445

Changes in cerebral blood flow and distribution associated with acute increases in plasma sodium and osmolality of chronic hyponatremic rats.

S Adler1, J G Verbalis, S Meyers, E Simplaceanu, D S Williams.   

Abstract

The cause of the osmotic demyelination syndrome that follows too rapid correction of chronic hyponatremia (CHN) is unknown. Recently, we reported in CHN rats an association between blood-brain barrier (BBB) disruption occurring as early as 3 h into correction and subsequent demyelination. Given the changes in brain water and blood volume which occur during correction of CHN, we hypothesized that the same correction protocol that causes demyelination might alter cerebral blood flow (CBF) during correction, thereby possibly contributing to BBB disruption and demyelination. Ten CHN rats were given hypertonic sodium intraperitoneally and its effect on CBF was continuously monitored for 3 h by magnetic resonance flow imaging. Over the subsequent 3 h, plasma sodium rose from 110.8 to 127.6 mEq/liter (P < 0.001) but neither mean arterial blood pressure nor arterial CO(2) tension changed significantly. By 30 min, CBF increased by 50% in cortical and subcortical areas (P < 0.001) and remained elevated for the next 60 min. After 2 h, cortical flow was no longer elevated significantly and by 3 h it had returned to control values. Subcortical flow, however, significantly exceeded control values throughout the 3 h so that after 2 h the ratio of cortical to subcortical blood flow had fallen from 1.17 to 0.91 (P < 0.05). Although the mechanism by which increased plasma sodium and osmolality alters CBF is uncertain, the results suggest that changes in CBF may be part of a cascade of cerebrovascular disturbances including endothelial or parenchymal damage, mechanical events, metabolic disturbances, or cytokine release which eventually lead to BBB disruption and subsequent demyelination. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785445     DOI: 10.1006/exnr.2000.7376

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Ultrastructural Analysis of Thalamus Damages in a Mouse Model of Osmotic-Induced Demyelination.

Authors:  Joanna Bouchat; Jacques Gilloteaux; Valérie Suain; Daniel Van Vlaender; Jean-Pierre Brion; Charles Nicaise
Journal:  Neurotox Res       Date:  2019-05-02       Impact factor: 3.911

Review 2.  Clinical semiology and neuroradiologic correlates of acute hypernatremic osmotic challenge in adults: a literature review.

Authors:  F Y Ismail; A Szóllics; M Szólics; N Nagelkerke; M Ljubisavljevic
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-14       Impact factor: 3.825

Review 3.  Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain.

Authors:  Lucinda J L Craggs; Yumi Yamamoto; Vincent Deramecourt; Raj N Kalaria
Journal:  Brain Pathol       Date:  2014-09       Impact factor: 6.508

Review 4.  New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2009-11-06       Impact factor: 3.714

5.  A Case of Osmotic Demyelination Presenting with Severe Hypernatremia.

Authors:  Min Jee Han; Do Hyoung Kim; Young Hwa Kim; In Mo Yang; Joon Hyung Park; Moon Ki Hong
Journal:  Electrolyte Blood Press       Date:  2015-06-30

6.  Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy.

Authors:  Kyung Yoon Chang; In-Hee Lee; Gi Jun Kim; Kangwon Cho; Hoon Suk Park; Hyung Wook Kim
Journal:  BMC Nephrol       Date:  2014-04-04       Impact factor: 2.388

Review 7.  Hyponatremia and the Brain.

Authors:  Fabrice Gankam Kengne; Guy Decaux
Journal:  Kidney Int Rep       Date:  2017-09-01

8.  Effect of vasopressin-induced chronic hyponatremia on the regulation of the middle cerebral artery of the rat.

Authors:  Marta Aleksandrowicz; Ewa Kozniewska
Journal:  Pflugers Arch       Date:  2018-03-17       Impact factor: 3.657

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.